All attending UK organisations

UK companies attending as part of the official delegation (The UK pavilion will be in Hall A, Stand 765)

Activinsights, Cell and Gene Therapy Catapult, docs24, Domainex, Dxcover, eXmoor Pharma, Genomics, hVIVO, Infinitopes, Invest Liverpool City Region, Invest Northern Ireland, MedCity/ London&Partners, Medicines Evaluation Unit, MERXIN, NIHR, Oxford (North & Science Park), PatientRx, Richmond Pharmacology, RxCelerate, Scottish Development International, Seda Pharmaceutical Development Services, UK Health Security Agency (UKHSA), UK Research & Innovation - STFC | Harwell Science and Innovation Campus (23).

Scottish delegation:

1nhaler, Axol Biosciences, BioAscent Discovery, Chemify, Chromatin Bioscience, Concinnity Genetics, Cumulus Oncology, Cytomos, Firefinch Software, Fitabeo Therapeutics, Glox Therapeutics, IDxSense, Lentitek, Libero Pharma, Medannex, mycoBiologics, Pheno Therapeutics, Pneumagen, Reprocell Europe, Resolution Therapeutics, RoukenBio (21).

Other UK companies associated with the delegation*:

ABPI, Activinsights, Alcyomics, Almac Discovery, ARC, Arecor Therapeutics, Barrington James, bit.bio, C4X Discovery, Cell and Gene Therapy Catapult, Crystec, DLRC, Evotec International, GreyRigge Associates, IDEA REGULATORY, Ignota Labs, ImmuONE, Intract Pharma, MediSieve, Mereo BioPharma Group, MesenBio, o2h, OutSee, Pencil Biosciences, PharmaVentures, PharmaVentures Capital, Physiomics, Pracipio, ProImmune, Prokarium, Qureight, Rosemont Pharmaceuticals, Sareum, SBA, Serenatis Bio, Silence Therapeutics, TheraCryf, Therakind, ValiRx, Vernalis, YAFO Capital (Shanghai) (37).

All attending UK companies:

See also the BIO Partnering list
1nhaler, 4basebio, 4C Biomed, 5654 & Company, AAVantgarde Bio, Corp USA, ABPI, Accession Therapeutics, Accord Healthcare, Activinsights , Advanz Pharma, Alan Boyd Consultants, Albion Capital Group, Almac Discovery, ALSA Ventures, Amphista Therapeutics, AMPLY Discovery, Apollo Therapeutics, Aptamer Group, Arecor Therapeutics, Aston University, Autolus, Avata Biosciences, Axiom Therapeutics, Axol Bioscience, Barrington James, BioAscent Discovery, BioProduction by SEKISUI, Bird & Bird, bit.bio, C4X Discovery, Cambridge Enterprise, Cancer Research UK, CardiaTec Bio, CatSci, Celerion, Cell and Gene Therapy Catapult, Centauri Therapeutics, Chemify, Chromatin Bioscience, Clarivate, Clickmer Systems - Apis Assay, Clinigen, Coding Bio, Cognite, Concinnity Genetics, Consilient Health, Constructive Bio, Creasallis, Crystec Pharma, Cumulus Oncology, Curve Therapeutics, Cytomos , Cytospire Therapeutics, Deep Science Ventures, Department for Business and Trade, DLRC, docs24, Domainex, Dxcover, Ellipses Pharma, EnsiliTech, EquipNet, Etcembly, Evaluate, Evariste, Evox Therapeutics, Fingerpost Consulting, Firefinch Software, Fitabeo Therapeutics, Fusion Antibodies, Genomics, George Medicines, Glox Therapeutics, Gowling WLG, Grey Wolf Therapeutics, GreyRigge Associates, GSK, Harness Therapeutics, Hikma Pharmaceuticals, hVIVO, Hyve, IDEA Regulatory, IDxSense, Ignota Labs, Immunocore, ImmuONE, IMU Biosciences, Inbeeo, Inceptua, Infinitopes, Intract Pharma, Invest Liverpool City Region, Invest Northern Ireland, iosBio, Isomorphic Labs, IXICO, Kesmalea Therapeutics, Kintiga, LabGenius, Lentitek, Leucid Bio, Libero Pharma, LIfT BioSciences, Lotus Pharmaceutical Co., LSX Leaders, M:M Bio, Macomics ., Medannex, MedCity/ London&Partners, Medicines Discovery Catapult, MediSieve, Mereo BioPharma, Merxin, Mesenbio, MEU, Microbiotica, MindRank, MNS, MultiOmic Health, Mursla Bio, mycoBiologics, NanoSyrinx, Negev Labs, NeoPhore, NIHR, Nucleome Therapeutics, O2H Ventures, Oak Hill Bio, Ochre Bio, Orbit Discovery, Orchard Therapeutics NA, OutSee, Oxford (North & Science Park), Oxford BioMedica, Oxford Biotherapeutics, Oxford Medical Products, Oxford University Innovation, Oxford Vacmedix, Pathios Therapeutics, PatientRx, PatSnap, PDR - International Centre for Design & Research, Pencil Biosciences, Pharmanovia, PharmaVentures, Pheno Therapeutics, Phoremost, PHYSIOMICS, Pneumagen, Pracipio, ProImmune, Prokarium, Purespring Therapeutics, Quell Tx, Qureight, Random42 & The Lockwood Group, RareGeniX Consulting, Reciprocal Space, Redx Pharma, ReNewVax, Reprocell, Resolution Therapeutics, Richmond Pharmacology, Rosemont Pharmaceuticals, Roslin Cell Therapies, RoukenBio, RQ Biotechnology, RxCelerate, Sareum, Sartorius, SBA, Scendea, Sciensus, Scottish Development International, Seda Pharmaceutical Development Services, SENTINEL ONCOLOGY, Serenatis Bio, Shield Therapeutics, SignaCor, Silence Therapeutics, Sitryx, Springer Nature, Spur Therapeutics, Stephenson Harwood, SV Health Investors, SynaptixBio, SynGenSys, T-Cypher Bio, The Institute of Cancer Research, The Science Behind, Theracryf, Theradex Oncology, Therakind, Theramex, TMC Pharma Services, tranScrip, UK Health Security Agency, UKRI - STFC, University of Bath, Upperton Pharma Solutions, ValRx, Vernalis Research, Viiv Healthcare, VirdisGroup, WAYMADE UK, Weatherden, Wellcome Sanger Institute, Wickenstones, Yaqrit (209).

*saved money by pre-registering through BioPartner UK. Our members are emboldened, find out more about them at https//:members.biopartner.co.uk